Align Technology (ALGN) Competitors $134.70 +2.35 (+1.78%) Closing price 04:00 PM EasternExtended Trading$133.98 -0.72 (-0.53%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALGN vs. DXCM, HQY, HSIC, MEDP, QTRX, CAH, HAE, MCK, RMD, and WSTShould you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), Quanterix (QTRX), Cardinal Health (CAH), Haemonetics (HAE), McKesson (MCK), ResMed (RMD), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Align Technology vs. Its Competitors DexCom HealthEquity Henry Schein Medpace Quanterix Cardinal Health Haemonetics McKesson ResMed West Pharmaceutical Services Align Technology (NASDAQ:ALGN) and DexCom (NASDAQ:DXCM) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation. Is ALGN or DXCM more profitable? DexCom has a net margin of 13.29% compared to Align Technology's net margin of 11.04%. DexCom's return on equity of 30.41% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Align Technology11.04% 13.36% 8.32% DexCom 13.29%30.41%10.08% Which has preferable earnings and valuation, ALGN or DXCM? DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlign Technology$4.00B2.44$421.36M$5.9322.72DexCom$4.03B7.85$576.20M$1.4456.08 Does the media refer more to ALGN or DXCM? In the previous week, Align Technology had 4 more articles in the media than DexCom. MarketBeat recorded 24 mentions for Align Technology and 20 mentions for DexCom. DexCom's average media sentiment score of 1.28 beat Align Technology's score of 1.05 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 15 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 17 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in ALGN or DXCM? 88.4% of Align Technology shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.7% of Align Technology shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, ALGN or DXCM? Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Comparatively, DexCom has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Do analysts rate ALGN or DXCM? Align Technology currently has a consensus target price of $215.00, suggesting a potential upside of 59.61%. DexCom has a consensus target price of $99.89, suggesting a potential upside of 23.69%. Given Align Technology's higher probable upside, equities research analysts clearly believe Align Technology is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Align Technology 2 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.50DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 2.95 SummaryDexCom beats Align Technology on 12 of the 17 factors compared between the two stocks. Get Align Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALGN vs. The Competition Export to ExcelMetricAlign TechnologyMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.59B$15.93B$5.75B$9.85BDividend YieldN/A1.51%6.67%4.51%P/E Ratio22.7217.9278.4326.42Price / Sales2.442.44546.94119.09Price / Cash14.7316.1137.0558.92Price / Book2.613.7810.916.06Net Income$421.36M$472.13M$3.29B$266.28M7 Day Performance-4.56%1.29%0.01%-0.76%1 Month Performance-2.23%4.09%7.06%3.83%1 Year Performance-39.42%7.89%50.09%24.39% Align Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALGNAlign Technology4.9848 of 5 stars$134.70+1.8%$215.00+59.6%-41.6%$9.59B$4.00B22.7220,945Positive NewsAnalyst DowngradeDXCMDexCom4.8963 of 5 stars$75.96-7.7%$99.89+31.5%+9.1%$29.79B$4.03B52.7510,300Positive NewsHQYHealthEquity3.6103 of 5 stars$87.42-2.7%$118.55+35.6%+21.5%$7.56B$1.20B63.813,120Trending NewsAnalyst ForecastHSICHenry Schein4.0739 of 5 stars$68.47-1.6%$75.58+10.4%-4.7%$8.30B$12.77B22.0925,000MEDPMedpace4.5428 of 5 stars$466.80+0.7%$406.60-12.9%+37.5%$13.11B$2.23B34.715,900News CoveragePositive NewsAnalyst DowngradeInsider TradeQTRXQuanterix2.583 of 5 stars$4.67-3.3%$11.75+151.6%-64.4%$217.00M$124.25M-2.57460Positive NewsCAHCardinal Health4.9775 of 5 stars$146.18-1.3%$163.20+11.6%+31.2%$34.91B$222.58B22.6657,700Trending NewsShort Interest ↑Analyst RevisionHAEHaemonetics4.8094 of 5 stars$55.30-1.9%$85.18+54.0%-28.9%$2.66B$1.36B16.913,023Positive NewsShort Interest ↑MCKMcKesson4.5073 of 5 stars$679.34-1.5%$725.10+6.7%+20.2%$84.50B$359.05B27.0945,000Positive NewsAnalyst RevisionRMDResMed4.7174 of 5 stars$285.76-2.7%$274.83-3.8%+9.8%$41.84B$5.15B30.0510,600Positive NewsAnalyst UpgradeWSTWest Pharmaceutical Services4.9616 of 5 stars$246.98-0.4%$320.71+29.9%-18.3%$17.76B$2.89B36.9710,600Positive News Related Companies and Tools Related Companies DXCM Alternatives HQY Alternatives HSIC Alternatives MEDP Alternatives QTRX Alternatives CAH Alternatives HAE Alternatives MCK Alternatives RMD Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALGN) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredNewegg (NEGG) Earns BULLISH Rating – Up 934%The last time he shared a free AI stock pick like this, it soared 100%.Chaikin Analytics | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Align Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Align Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALGN Stock Alerts